Variant report

Variant	nsv1011019
Chromosome Location	chr2:142314999-142430460
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:357)
CpG islands
(count:183)
Chromatin interactive
region (count:20)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:357 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr2:142314780-142315309	GM12878	blood:	n/a	n/a
2	ATF2	chr2:142314848-142315209	GM12878	blood:	n/a	n/a
3	CEBPB	chr2:142346952-142347268	MCF-7	breast:	n/a	n/a
4	CEBPB	chr2:142340634-142340918	A549	lung:	n/a	chr2:142340775-142340786 chr2:142340777-142340786
5	CEBPB	chr2:142391093-142391444	HepG2	liver:	n/a	chr2:142391396-142391409 chr2:142391248-142391259 chr2:142391396-142391407
6	CEBPB	chr2:142340638-142340962	HepG2	liver:	n/a	chr2:142340775-142340786 chr2:142340777-142340786
7	CEBPB	chr2:142346903-142347248	A549	lung:	n/a	n/a
8	CEBPB	chr2:142346888-142347264	IMR90	lung:	n/a	n/a
9	CEBPB	chr2:142388316-142388330	HepG2	liver:	n/a	n/a
10	CEBPB	chr2:142346890-142347263	HepG2	liver:	n/a	n/a
11	CEBPB	chr2:142323048-142323653	MCF-7	breast:	n/a	n/a
12	CEBPB	chr2:142314948-142315216	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr2:142346898-142347242	ECC-1	luminal epithelium:	n/a	n/a
14	CEBPB	chr2:142368559-142369062	Hela-S3	cervix:	n/a	chr2:142368869-142368882
15	CEBPB	chr2:142346949-142347256	Hela-S3	cervix:	n/a	n/a
16	CEBPB	chr2:142346890-142347265	H1-hESC	embryonic stem cell:	n/a	n/a
17	CEBPB	chr2:142314951-142315151	A549	lung:	n/a	n/a
18	CEBPB	chr2:142319981-142320458	MCF-7	breast:	n/a	chr2:142320205-142320216 chr2:142320207-142320216
19	CEBPB	chr2:142414231-142414544	HepG2	liver:	n/a	chr2:142414400-142414411 chr2:142414398-142414411 chr2:142414398-142414409 chr2:142414398-142414411
20	CEBPB	chr2:142346857-142347357	A549	lung:	n/a	n/a
21	CEBPB	chr2:142346926-142347249	K562	blood:	n/a	n/a
22	CEBPB	chr2:142320153-142320282	K562	blood:	n/a	chr2:142320205-142320216 chr2:142320207-142320216
23	CEBPB	chr2:142374381-142374819	MCF-7	breast:	n/a	n/a
24	CEBPB	chr2:142320032-142320365	HepG2	liver:	n/a	chr2:142320205-142320216 chr2:142320207-142320216
25	CEBPB	chr2:142314830-142315261	IMR90	lung:	n/a	n/a
26	CEBPB	chr2:142323069-142323584	MCF-7	breast:	n/a	n/a
27	CEBPB	chr2:142340629-142340928	IMR90	lung:	n/a	chr2:142340775-142340786 chr2:142340777-142340786
28	CEBPB	chr2:142398949-142399398	Hela-S3	cervix:	n/a	n/a
29	CEBPB	chr2:142346893-142347268	A549	lung:	n/a	n/a
30	CEBPB	chr2:142374350-142374784	MCF-7	breast:	n/a	n/a
31	CEBPB	chr2:142346438-142346646	HepG2	liver:	n/a	n/a
32	CEBPB	chr2:142414267-142414467	A549	lung:	n/a	chr2:142414400-142414411 chr2:142414398-142414411 chr2:142414398-142414409 chr2:142414398-142414411
33	CEBPB	chr2:142320051-142320366	H1-hESC	embryonic stem cell:	n/a	chr2:142320205-142320216 chr2:142320207-142320216
34	CEBPB	chr2:142391188-142391388	H1-hESC	embryonic stem cell:	n/a	chr2:142391248-142391259
35	CEBPB	chr2:142368691-142368945	IMR90	lung:	n/a	chr2:142368869-142368882
36	CTCF	chr2:142427511-142427549	GM20000	blood:	n/a	n/a
37	CTCF	chr2:142374420-142374451	Lung_OC	lung:	n/a	n/a
38	CTCF	chr2:142331591-142331595	Kidney_OC	kidney:	n/a	n/a
39	CTCF	chr2:142339860-142340010	NB4	blood:	n/a	n/a
40	CTCF	chr2:142426840-142426990	MCF-7	breast:	n/a	n/a
41	CTCF	chr2:142321273-142321326	Lung_OC	lung:	n/a	n/a
42	CTCF	chr2:142331599-142331636	Kidney_OC	kidney:	n/a	n/a
43	CTCF	chr2:142426774-142426959	MCF-7	breast:	n/a	n/a
44	CTCF	chr2:142426840-142426858	LNCaP	prostate:	n/a	n/a
45	CTCF	chr2:142426866-142426918	HUVEC	blood vessel:	n/a	n/a
46	CTCF	chr2:142426798-142426948	LNCaP	prostate:	n/a	n/a
47	CTCF	chr2:142426800-142426950	AG04450	lung:	n/a	n/a
48	CTCF	chr2:142327900-142328050	WERI-Rb-1	eye:	n/a	n/a
49	CTCF	chr2:142426800-142426950	MCF-7	breast:	n/a	n/a
50	CTCF	chr2:142426811-142426936	MCF-7	breast:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:142369345-142369395	MCF10A-Er-Src	breast:	n/a
2	chr2:142369345-142369395	GM12892	blood:	n/a
3	chr2:142369345-142369395	ovcar-3	ovarian:	n/a
4	chr2:142338869-142338919	PFSK-1	brain:	n/a
5	chr2:142416800-142416850	HCM	heart:	n/a
6	chr2:142369345-142369395	HPAEpiC	pulmonary alveolar:	n/a
7	chr2:142416800-142416850	RPTEC	kidney:	n/a
8	chr2:142369345-142369395	RPTEC	kidney:	n/a
9	chr2:142416800-142416850	GM12878	blood:	n/a
10	chr2:142338869-142338919	ECC-1	luminal epithelium:	n/a
11	chr2:142416800-142416850	AG10803	skin:	n/a
12	chr2:142369345-142369395	HRPEpiC	eye:	n/a
13	chr2:142338869-142338919	NHDF-neo	bronchial:	n/a
14	chr2:142338869-142338919	LNCaP	prostate:	n/a
15	chr2:142369345-142369395	SK-N-MC	brain:	n/a
16	chr2:142416800-142416850	K562	blood:	n/a
17	chr2:142416800-142416850	CMK	blood:	n/a
18	chr2:142338869-142338919	HNPCEpiC	eye:	n/a
19	chr2:142369345-142369395	LNCaP	prostate:	n/a
20	chr2:142416800-142416850	HRPEpiC	eye:	n/a
21	chr2:142416800-142416850	HAEpiC	amniotic membrane:	n/a
22	chr2:142369345-142369395	A549	lung:	n/a
23	chr2:142338869-142338919	GM06990	blood:	n/a
24	chr2:142338869-142338919	H1-hESC	embryonic stem cell:	embryo
25	chr2:142338869-142338919	HEK293	kidney:	embryo
26	chr2:142416800-142416850	GM06990	blood:	n/a
27	chr2:142338869-142338919	HIPEpiC	eye:	n/a
28	chr2:142416800-142416850	U87	brain:	n/a
29	chr2:142338869-142338919	SKMC	muscle:	n/a
30	chr2:142369345-142369395	NT2-D1	testis:	n/a
31	chr2:142416800-142416850	BJ	skin:	n/a
32	chr2:142338869-142338919	T-47D	breast:	n/a
33	chr2:142369345-142369395	SK-N-SH_RA	brain:	n/a
34	chr2:142416800-142416850	HUVEC	blood vessel:	n/a
35	chr2:142338869-142338919	HPAEpiC	pulmonary alveolar:	n/a
36	chr2:142416800-142416850	ECC-1	luminal epithelium:	n/a
37	chr2:142338869-142338919	Jurkat	blood:	n/a
38	chr2:142369345-142369395	HIPEpiC	eye:	n/a
39	chr2:142416800-142416850	ovcar-3	ovarian:	n/a
40	chr2:142338869-142338919	IMR90	lung:	fetal
41	chr2:142416800-142416850	GM19239	blood:	n/a
42	chr2:142369345-142369395	SAEC	small airway:	n/a
43	chr2:142416800-142416850	BE2_C	brain:	n/a
44	chr2:142416800-142416850	A549	lung:	n/a
45	chr2:142338869-142338919	GM12891	blood:	n/a
46	chr2:142369345-142369395	GM12878	blood:	n/a
47	chr2:142369345-142369395	BE2_C	brain:	n/a
48	chr2:142369345-142369395	Hepatocyte	liver:	n/a
49	chr2:142338869-142338919	Hela-S3	cervix:	n/a
50	chr2:142416800-142416850	H1-hESC	embryonic stem cell:	embryo

(count:20 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:142363098..142365424-chr2:142366631..142368354,2	MCF-7	breast:
2	chr2:142267530..142270120-chr2:142367084..142369508,2	MCF-7	breast:
3	chr2:142399705..142402607-chr2:142407743..142409987,2	MCF-7	breast:
4	chr2:142399705..142402607-chr2:142407743..142409987,2	MCF-7	breast:
5	chr2:142386784..142389689-chr2:142401427..142404139,2	MCF-7	breast:
6	chr2:142386784..142389689-chr2:142401427..142404139,2	MCF-7	breast:
7	chr2:142322809..142324424-chr2:142379273..142380846,2	MCF-7	breast:
8	chr2:142348226..142350841-chr2:142353391..142355433,2	MCF-7	breast:
9	chr2:142363098..142365424-chr2:142366631..142368354,2	MCF-7	breast:
10	chr2:142259500..142260427-chr2:142322823..142323400,2	MCF-7	breast:
11	chr2:142317711..142321512-chr2:142324977..142327310,3	MCF-7	breast:
12	chr2:142322809..142324424-chr2:142379273..142380846,2	MCF-7	breast:
13	chr2:142399092..142400937-chr2:142401190..142403149,2	MCF-7	breast:
14	chr2:142308972..142312076-chr2:142313360..142316898,3	K562	blood:
15	chr2:142398871..142401024-chr2:142404435..142406777,2	MCF-7	breast:
16	chr2:142317711..142321512-chr2:142324977..142327310,3	MCF-7	breast:
17	chr2:142398871..142401024-chr2:142404435..142406777,2	MCF-7	breast:
18	chr2:142348226..142350841-chr2:142353391..142355433,2	MCF-7	breast:
19	chr2:142399092..142400937-chr2:142401190..142403149,2	MCF-7	breast:
20	chr2:142320561..142322150-chr2:142885194..142887458,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000265224	TF binding region
ENSG00000265224	CpG island

Extended variants
information (count: 2491 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:2491 , 50 per page) page: 1 2 3 4 5 6 7 ... 50

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs368730758	chr2:142315007-142315008	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs80288905	chr2:142315008-142315009	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs149706191	chr2:142315009-142315010	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs145568324	chr2:142315017-142315018	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs562791327	chr2:142315019-142315020	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs547952068	chr2:142315080-142315081	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs533121143	chr2:142315127-142315128	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs536674200	chr2:142315128-142315129	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs551529916	chr2:142315173-142315174	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs181080088	chr2:142315193-142315194	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs576422439	chr2:142315205-142315206	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs538800493	chr2:142315260-142315261	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs142881345	chr2:142315288-142315289	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs184711324	chr2:142315295-142315296	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs72853591	chr2:142315346-142315347	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs72976082	chr2:142315357-142315358	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs534750904	chr2:142315390-142315391	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs543046326	chr2:142315392-142315393	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs35714902	chr2:142315485-142315486	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs531932207	chr2:142315494-142315495	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs114583643	chr2:142315505-142315506	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs565347130	chr2:142315506-142315507	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs189882444	chr2:142315542-142315543	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs115158974	chr2:142315565-142315566	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs79062359	chr2:142315601-142315602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs147661450	chr2:142315610-142315611	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs550222319	chr2:142315619-142315620	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs569888140	chr2:142315640-142315641	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs367547521	chr2:142315723-142315724	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs10165850	chr2:142315735-142315736	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs558851280	chr2:142315814-142315815	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs566885745	chr2:142315837-142315838	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs73965708	chr2:142315857-142315858	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs534535854	chr2:142315877-142315878	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs73965709	chr2:142315890-142315891	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs10178630	chr2:142315893-142315894	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs542985003	chr2:142315920-142315921	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs536340670	chr2:142315926-142315927	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs555935209	chr2:142315936-142315937	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs576634934	chr2:142315970-142315971	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs142365023	chr2:142316046-142316047	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs545404116	chr2:142316071-142316072	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs559649466	chr2:142316076-142316077	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs10168763	chr2:142316115-142316116	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs17617659	chr2:142316123-142316124	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs541660948	chr2:142316128-142316129	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs561342128	chr2:142316139-142316140	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs554373319	chr2:142316165-142316166	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs16846463	chr2:142316255-142316256	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs185946956	chr2:142316283-142316284	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Mental retardation	22214275	CNVD
Myelofibrosis	22110671	CNVD
Neuroblastoma	21899760	CNVD
Glioblastoma multiforme	19435819	CNVD
Glioblastoma multiforme	22286061	CNVD
Glioblastoma	21080181	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Autism	22543975	CNVD
Cancer	20164920	CNVD
Hypertension	22686481	CNVD
Hypospadia	22686481	CNVD
Intellectual disability	22686481	CNVD
Omphalocele	22686481	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Prostate cancer	22341455	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:219 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:142313600-142315800	Enhancers	NH-A	brain
2	chr2:142313600-142316000	Enhancers	Muscle Satellite Cultured Cells	--
3	chr2:142313800-142315800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr2:142313800-142316000	Enhancers	HMEC	breast
5	chr2:142314000-142315000	Weak transcription	Brain Hippocampus Middle	brain
6	chr2:142314200-142315200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr2:142314200-142315200	Enhancers	Brain Inferior Temporal Lobe	brain
8	chr2:142314200-142315800	Enhancers	Primary hematopoietic stem cells short term culture	blood
9	chr2:142314200-142316000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr2:142314400-142316000	Enhancers	Primary hematopoietic stem cells	blood
11	chr2:142314800-142315000	Enhancers	HUES64 Cell Line	embryonic stem cell
12	chr2:142314800-142315000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr2:142314800-142315200	Enhancers	H1 Cell Line	embryonic stem cell
14	chr2:142314800-142315200	Enhancers	H9 Cell Line	embryonic stem cell
15	chr2:142314800-142315200	Enhancers	HUES48 Cell Line	embryonic stem cell
16	chr2:142314800-142315200	Enhancers	iPS-15b Cell Line	embryonic stem cell
17	chr2:142314800-142315200	Enhancers	iPS-18 Cell Line	embryonic stem cell
18	chr2:142314800-142315200	Enhancers	Monocytes-CD14+_RO01746	blood
19	chr2:142314800-142315400	Enhancers	HUVEC	blood vessel
20	chr2:142314800-142315800	Enhancers	NHEK	skin
21	chr2:142315000-142315200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr2:142315000-142315200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr2:142315000-142315400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
24	chr2:142315000-142315400	Enhancers	Primary monocytes fromperipheralblood	blood
25	chr2:142315000-142315600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr2:142315000-142315600	Enhancers	Pancreas	Pancrea
27	chr2:142315200-142315400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr2:142315200-142315400	Enhancers	Brain Hippocampus Middle	brain
29	chr2:142315200-142315600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
30	chr2:142315200-142315600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr2:142315200-142315600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr2:142315200-142316200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
33	chr2:142315200-142317400	Weak transcription	HUES48 Cell Line	embryonic stem cell
34	chr2:142315200-142318000	Weak transcription	HUES64 Cell Line	embryonic stem cell
35	chr2:142315200-142322600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
36	chr2:142315200-142327800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
37	chr2:142315400-142315600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
38	chr2:142315400-142316400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr2:142315400-142320000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
40	chr2:142316200-142316400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr2:142316400-142318000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr2:142317400-142318200	Enhancers	HUES48 Cell Line	embryonic stem cell
43	chr2:142317600-142318000	Enhancers	Stomach Mucosa	stomach
44	chr2:142318000-142318200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr2:142318000-142318200	Enhancers	HUES64 Cell Line	embryonic stem cell
46	chr2:142318200-142322200	Weak transcription	HUES48 Cell Line	embryonic stem cell
47	chr2:142318200-142322600	Weak transcription	HUES64 Cell Line	embryonic stem cell
48	chr2:142320000-142320400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
49	chr2:142320400-142327800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
50	chr2:142322200-142323400	Enhancers	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links